[Toxoplasmic @entity6519 complicated by XXXX ].

@entity1 @entity2194 @entity937 @entity1713 @entity2318 @entity228 @entity134 @entity29628 @entity56 @entity6519 @entity6619
PURPOSE: To describe and analyse relationship between @entity6519 and @entity1713 . @entity1 AND METHODS: Seven immunocompetent @entity1 examined and treated between November 1992 and March 1996, with @entity2194 and @entity1713 . RESULTS: Of the 7 @entity1 examined, 5 had active retinochoroiditis and 2 had typical inactive scars. Of the @entity1 with active focus 3 had @entity937 , one had a posterior retinal tear and one had a retinal tear located at the edge of an @entity2318 . Of the @entity1 with inactive lesions, one had tractional @entity1713 and the other presented with a complete @entity1713 , multiples tears and @entity29628 . Five @entity1 were treated by @entity228 without antitoxoplasmic drug before they were referred. The seven @entity1 underwent endo-ocular surgery with @entity6619 oil or long actic gas tamponade. Three @entity1 developed @entity29628 and redetachment of the retina and two @entity1 underwent further surgery. Good anatomical result was obtained in 6 @entity1 . CONCLUSION: @entity1713 associated with toxoplasmic retinochoroiditis is rare. However it represents a serious complication. @entity134 administrated to salvage vision may then worsen the clinical course, these may be justified to reduce @entity56 to toxoplasma antigen, but they should be combined with an antimicrobial agent.
